Backlash grows against Mylan’s EpiPen price hikes
August 24, 2016 at 18:02 PM EDT
Mylan NV became the latest pharmaceutical company to face popular outrage about higher drug costs, as attacks mounted Wednesday on the company’s substantial price increases for the EpiPen emergency allergy treatment.